Folder With News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Folder with. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Folder With Today - Breaking & Trending Today

Immunotherapy vs Chemoimmunotherapy in Older Adults With Advanced NSCLC

1. Adding chemotherapy to immunotherapy did not prolong OS or PFS, with non-significant differences in HR. 2. Grade 3 or higher immune-related adverse events occurred in 24.3% and 17.9% in the ICI-chemotherapy and ICI-alone groups. Evidence Rating Level: 2 (Good) Study Rundown: Immune checkpoint inhibitors (ICIs) have significantly improved outcomes in non-small cell lung cancer ....

Rating Level , Clinical Outcomes , Toxic Effects , Folder With ,